New ISS Chief Signals Continued Growth in Republic of Korea

There’s a famous Korean proverb that goes, “The person who knows himself and his opponent will be invincible. Carve a peg only after you have observed the hole." An application for that wisdom can be seen in Battelle’s ongoing, strategic effort to continually improve the positioning of its spinoff company International Scientific Standard (ISS), not only in the South Korean but the wider Asian market.

The company continues to grow via a transition at the chief executive officer level. After a two-year commitment to set up a world-class good laboratory practice (GLP) operations to serve the Korean and global biopharma industry, the planned transition from President and CEO Mr. Victor Moore to Dr. Youngshin Lee took effect Sept. 6.

“Youngshin comes to us from a very impressive background in international/multinational companies, where she has an established track record in delivering a high level of client satisfaction and scientific excellence,” said Barbara Kunz, Battelle’s President of Health and Life Sciences Global Business. Battelle continues to have a strong commitment to supporting the innovation agendas for health and life sciences industry in Korea.

Mr. Moore was highly successful in building the company into a professional contract research and development organization. Dr. Lee now will guide ISS into a world-renowned company providing various high level quality services including bioequivalence and clinical sample analysis and delivering greater speed in time to market. ISS offers a full suite of services to support drug discovery and development, including preclinical toxicology, biomarkers services, biologics analysis, and drug delivery technologies, offered through the Battelle laboratories.

About Battelle

As the world’s largest, independent research and development organization, Battelle provides innovative solutions to the world’s most pressing needs through its four global businesses: Laboratory Management, National Security, Energy Technology, and Health and Life Sciences. It advances scientific discovery and application by conducting $6.2 billion in global R&D annually through contract research, laboratory management and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and a nuclear energy lab in the United Kingdom. Battelle also is one of the nation’s leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science and math education. Media contacts: Katy Delaney at (614) 424-7208, or T.R. Massey at (614) 424-5544.